vs

Side-by-side financial comparison of Accelerant Holdings (ARX) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

Accelerant Holdings is the larger business by last-quarter revenue ($267.4M vs $221.4M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 0.2% vs -511.9%, a 512.1% gap on every dollar of revenue.

Accelerant Holdings is a global specialty insurance and reinsurance technology platform that leverages advanced data analytics and risk assessment tools to support insurance carriers, managing general agents, and underwriting partners. It delivers tailored risk solutions, streamlines underwriting workflows, and serves commercial and specialty insurance segments across North America and European markets.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

ARX vs UTI — Head-to-Head

Bigger by revenue
ARX
ARX
1.2× larger
ARX
$267.4M
$221.4M
UTI
Higher net margin
UTI
UTI
512.1% more per $
UTI
0.2%
-511.9%
ARX

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
ARX
ARX
UTI
UTI
Revenue
$267.4M
$221.4M
Net Profit
$-1.4B
$433.0K
Gross Margin
Operating Margin
-507.7%
0.2%
Net Margin
-511.9%
0.2%
Revenue YoY
6.7%
Net Profit YoY
-60.5%
EPS (diluted)
$-6.99
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARX
ARX
UTI
UTI
Q1 26
$221.4M
Q4 25
$220.8M
Q3 25
$267.4M
$222.4M
Q2 25
$219.1M
$204.3M
Q1 25
$207.4M
Q4 24
$201.4M
Q3 24
$196.4M
Q2 24
$177.5M
Net Profit
ARX
ARX
UTI
UTI
Q1 26
$433.0K
Q4 25
$12.8M
Q3 25
$-1.4B
$18.8M
Q2 25
$8.8M
$10.7M
Q1 25
$11.4M
Q4 24
$22.2M
Q3 24
$18.8M
Q2 24
$5.0M
Operating Margin
ARX
ARX
UTI
UTI
Q1 26
0.2%
Q4 25
7.1%
Q3 25
-507.7%
11.2%
Q2 25
10.2%
6.9%
Q1 25
8.1%
Q4 24
13.6%
Q3 24
13.3%
Q2 24
4.2%
Net Margin
ARX
ARX
UTI
UTI
Q1 26
0.2%
Q4 25
5.8%
Q3 25
-511.9%
8.4%
Q2 25
4.0%
5.2%
Q1 25
5.5%
Q4 24
11.0%
Q3 24
9.6%
Q2 24
2.8%
EPS (diluted)
ARX
ARX
UTI
UTI
Q1 26
$0.01
Q4 25
$0.23
Q3 25
$-6.99
$0.33
Q2 25
$0.04
$0.19
Q1 25
$0.21
Q4 24
$0.40
Q3 24
$0.35
Q2 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARX
ARX
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$1.6B
$162.0M
Total DebtLower is stronger
$121.9M
$127.8M
Stockholders' EquityBook value
$676.1M
$339.9M
Total Assets
$7.9B
$852.2M
Debt / EquityLower = less leverage
0.18×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARX
ARX
UTI
UTI
Q1 26
$162.0M
Q4 25
$162.8M
Q3 25
$1.6B
$169.1M
Q2 25
$1.4B
$70.7M
Q1 25
$96.0M
Q4 24
$172.0M
Q3 24
$161.9M
Q2 24
$115.5M
Total Debt
ARX
ARX
UTI
UTI
Q1 26
$127.8M
Q4 25
$101.4M
Q3 25
$121.9M
$87.1M
Q2 25
$126.7M
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
ARX
ARX
UTI
UTI
Q1 26
$339.9M
Q4 25
$335.9M
Q3 25
$676.1M
$328.1M
Q2 25
$346.2M
$306.8M
Q1 25
$293.9M
Q4 24
$280.0M
Q3 24
$260.2M
Q2 24
$239.4M
Total Assets
ARX
ARX
UTI
UTI
Q1 26
$852.2M
Q4 25
$834.0M
Q3 25
$7.9B
$826.1M
Q2 25
$7.5B
$740.8M
Q1 25
$720.4M
Q4 24
$753.8M
Q3 24
$744.6M
Q2 24
$706.0M
Debt / Equity
ARX
ARX
UTI
UTI
Q1 26
0.38×
Q4 25
0.30×
Q3 25
0.18×
0.27×
Q2 25
0.37×
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARX
ARX
UTI
UTI
Operating Cash FlowLast quarter
$73.9M
$7.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
16.33×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARX
ARX
UTI
UTI
Q1 26
$7.1M
Q4 25
$3.1M
Q3 25
$73.9M
$57.1M
Q2 25
$309.3M
$18.1M
Q1 25
$-789.0K
Q4 24
$23.0M
Q3 24
$67.5M
Q2 24
$10.0M
Free Cash Flow
ARX
ARX
UTI
UTI
Q1 26
Q4 25
$-19.2M
Q3 25
$40.6M
Q2 25
$6.8M
Q1 25
$-11.7M
Q4 24
$19.6M
Q3 24
$60.0M
Q2 24
$3.0M
FCF Margin
ARX
ARX
UTI
UTI
Q1 26
Q4 25
-8.7%
Q3 25
18.3%
Q2 25
3.4%
Q1 25
-5.7%
Q4 24
9.7%
Q3 24
30.6%
Q2 24
1.7%
Capex Intensity
ARX
ARX
UTI
UTI
Q1 26
Q4 25
10.1%
Q3 25
7.4%
Q2 25
5.5%
Q1 25
5.3%
Q4 24
1.7%
Q3 24
3.8%
Q2 24
4.0%
Cash Conversion
ARX
ARX
UTI
UTI
Q1 26
16.33×
Q4 25
0.24×
Q3 25
3.04×
Q2 25
35.15×
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARX
ARX

Underwriting Segment$117.6M44%
Exchange Services Segment$85.0M32%
Other$64.8M24%

UTI
UTI

Segment breakdown not available.

Related Comparisons